Anticancer Therapeutic Alginate-Based Tissue Sealants for Lung Repair

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Polymer Chemistry

Background:

• Lung injuries from trauma, surgery, or disease pose significant clinical challenges.
• Current treatments for lung injuries have limitations in sealing air/fluid leaks and adhering to damaged tissue.
• There is a need for advanced biomaterials to effectively patch lung injuries and support healing.

Purpose of the Study:

• To develop an adherent hydrogel sealant patch system for lung injuries.
• To create a system capable of sealing damaged lung tissues and sustaining physiological pressures.
• To investigate the potential for drug delivery using these hydrogel patches.

Main Methods:

• Alginate was modified via methacrylation (AMA) and oxidation (AMA-DA) to create cross-linkable components.
• Hydrogel patches were fabricated by blending AMA and AMA-DA with a photoinitiator system.
• The patch system's mechanical properties (burst pressure) and biocompatibility were evaluated.
• Drug-eluting capabilities were assessed using doxorubicin-encapsulated submicrospheres.

Main Results:

• The blended AMA/AMA-DA hydrogel patches demonstrated enhanced burst pressure performance and reduced delamination compared to pure AMA.
• The hydrogel patches maintained human mesothelial cell (MeT-5A) viability and showed no cytotoxicity.
• Doxorubicin-loaded patches effectively reduced human lung cancer cell (A549) viability, indicating successful drug delivery.

Conclusions:

• The developed alginate-based hydrogel sealant patch system is effective for sealing lung injuries and withstanding physiological pressures.
• The blend of modified alginates improves mechanical integrity and adhesion of the sealant patches.
• The hydrogel system shows potential as a drug-eluting platform for targeted lung cancer therapy.